The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The predictive potential of the spatial signature of lymphocytes in breast cancer patients.
 
Nora Balint-Lahat
No Relationships to Disclose
 
Chen Mayer
No Relationships to Disclose
 
Noa Ben-Baruch
No Relationships to Disclose
 
Ady Yosepovich
No Relationships to Disclose
 
Kira Sacks
Employment - Nucleai
 
Shahar Ish-Shalom
No Relationships to Disclose
 
Yossef Molchanov
No Relationships to Disclose
 
Maya Dadiani
No Relationships to Disclose
 
Dana Morzaev-Sulzbach
No Relationships to Disclose
 
Einav Nili Gal-Yam
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Albert Achtenberg
Employment - Nucleai
 
Yuval Gabay
Employment - Nucleai
 
Roman Gluskin
Employment - Nucleai
 
Alon Griosman
Employment - Nucleai
 
Yuval Shachaf
Employment - Nucleai
 
Amir Luchtenstein
Employment - Nucleai
 
Ori Zelichov
Employment - Nucleai
 
Kathrina Alexander
Consulting or Advisory Role - Nucleai
 
Alexander J. Lazar
Leadership - Archer; Iterion Therapeutics; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Deciphera; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Iris Barshack
No Relationships to Disclose